Parkinson’s Disease and Melanoma: Co-Occurrence and Mechanisms

Parkinson Disease and Melanoma

(2017) Lauren A. Dalvin et al.   MAYO CLINIC PROCEEDINGS

Treatment with diphenyl–pyrazole compound anle138b/c reveals that α-synuclein protects melanoma cells from autophagic cell death

(2017) Elisa Turriani et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Cutaneous malignant melanoma and Parkinson disease: Common pathways?

(2016) Rivka Inzelberg et al.   ANNALS OF NEUROLOGY

Parkin Somatic Mutations Link Melanoma and Parkinson's Disease

(2016) Lotan Levin et al.   Journal of Genetics and Genomics

Rare variants analysis of cutaneous malignant melanoma genes in Parkinson's disease

(2016) S.J. Lubbe et al.   NEUROBIOLOGY OF AGING

Prodromal symptoms of Parkinson's disease: Implications for epidemiological studies of disease etiology

(2016) A. Elbaz   REVUE NEUROLOGIQUE

TheMC1Rmelanoma risk variant p.R160W is associated with Parkinson disease

(2015) Gemma Tell-Marti et al.   ANNALS OF NEUROLOGY

Frequency and profile of Parkinson's disease prodromi in patients with malignant melanoma

(2015) Uwe Walter et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

The Melanocortin 1 Receptor (Mc1r) Variants Do Not Account for the Co-occurrence of Parkinson's Disease and Malignant Melanoma

(2014) Sandra Elincx-Benizri et al.   JOURNAL OF MOLECULAR NEUROSCIENCE

The prevalence of Parkinson's disease: A systematic review and meta-analysis

(2014) Tamara Pringsheim et al.   MOVEMENT DISORDERS

Malignant melanoma in early-treated Parkinson's disease: The NET-PD trial

(2013) Radu Constantinescu et al.   MOVEMENT DISORDERS

Specific Pesticide-Dependent Increases in α-Synuclein Levels in Human Neuroblastoma (SH-SY5Y) and Melanoma (SK-MEL-2) Cell Lines

(2013) Areski Chorfa et al.   TOXICOLOGICAL SCIENCES

Sonographic abnormality of the substantia nigra in melanoma patients

(2012) Jost-Julian Rumpf et al.   MOVEMENT DISORDERS

Increased Melanoma Risk in Parkinson Disease

(2010) John M. Bertoni   ARCHIVES OF NEUROLOGY

Chaperone-Mediated Autophagy Markers in Parkinson Disease Brains

(2010) Lydia Alvarez-Erviti et al.   ARCHIVES OF NEUROLOGY

Endogenous 3,4-Dihydroxyphenylalanine and Dopaquinone Modifications on Protein Tyrosine

(2010) Xu Zhang et al.   MOLECULAR & CELLULAR PROTEOMICS

Cancer incidence in a trial of an antiapoptotic agent for Parkinson's disease

(2010) Steven R. Schwid et al.   MOVEMENT DISORDERS

A case-control study of Parkinson's disease and tobacco use: Gene-tobacco interactions

(2010) Giuseppe De Palma et al.   MOVEMENT DISORDERS

HIF-1 antagonizes p53-mediated apoptosis through a secreted neuronal tyrosinase

(2010) Ataman Sendoel et al.   NATURE

Targeting mutant BRAF in metastatic melanoma

(2010) Alexandra Flemming   NATURE REVIEWS DRUG DISCOVERY

 -SYNUCLEIN ACCUMULATION IN SKIN NERVE FIBERS REVEALED BY SKIN BIOPSY IN PURE AUTONOMIC FAILURE

(2010) T. Shishido et al.   NEUROLOGY

Common pathogenic pathways in melanoma and Parkinson disease

(2010) C. Paisan-Ruiz et al.   NEUROLOGY

Mutations inGNA11in Uveal Melanoma

(2010) Catherine D. Van Raamsdonk et al.   NEW ENGLAND JOURNAL OF MEDICINE

Genetic determinants at the interface of cancer and neurodegenerative disease

(2010) L G T Morris et al.   ONCOGENE

Parkinson's Disease-Related Protein, α-Synuclein, in Malignant Melanoma

(2010) Yasuhiro Matsuo et al.   PLoS One

ARF, autophagy and tumor suppression

(2009) Julia Pimkina et al.   Autophagy

Update in the epidemiology of Parkinsonʼs disease

(2009) Alexis Elbaz et al.   CURRENT OPINION IN NEUROLOGY

Beclin 1 and LC3 autophagic gene expression in cutaneous melanocytic lesions

(2009) Clelia Miracco et al.   HUMAN PATHOLOGY

Autophagy in cutaneous malignant melanoma

(2009) Rossitza Lazova et al.   JOURNAL OF CUTANEOUS PATHOLOGY

Multiple Pigmentation Gene Polymorphisms Account for a Substantial Proportion of Risk of Cutaneous Malignant Melanoma

(2009) David L. Duffy et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Genome-wide association study identifies variants at 9p21 and 22q13 associated with development of cutaneous nevi

(2009) Mario Falchi et al.   NATURE GENETICS

Somatic mutations of the Parkinson's disease–associated gene PARK2 in glioblastoma and other human malignancies

(2009) Selvaraju Veeriah et al.   NATURE GENETICS

Genome-wide association study identifies three loci associated with melanoma risk

(2009) D Timothy Bishop et al.   NATURE GENETICS

Family history of melanoma and Parkinson disease risk

(2009) X. Gao et al.   NEUROLOGY

Cancer risk in association with Parkinson disease: A population-based study

(2009) Claudia Becker et al.   PARKINSONISM & RELATED DISORDERS

Characterization of PLA2G6 as a locus for dystonia-parkinsonism

(2008) Coro Paisan-Ruiz et al.   ANNALS OF NEUROLOGY

Autophagy: A lysosomal degradation pathway with a central role in health and disease

(2008) Eeva-Liisa Eskelinen et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH

The role of autophagy-lysosome pathway in neurodegeneration associated with Parkinson's disease

(2008) T. Pan et al.   BRAIN

Nevus density and melanoma risk in women: A pooled analysis to test the divergent pathway hypothesis

(2008) Catherine M. Olsen et al.   INTERNATIONAL JOURNAL OF CANCER

The Reaction of α-Synuclein with Tyrosinase

(2008) Isabella Tessari et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Lewy Body Pathology Involves Cutaneous Nerves

(2008) Masako Ikemura et al.   JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY

Autophagy fights disease through cellular self-digestion

(2008) Noboru Mizushima et al.   NATURE

ASIP and TYR pigmentation variants associate with cutaneous melanoma and basal cell carcinoma

(2008) Daniel F Gudbjartsson et al.   NATURE GENETICS

Secretion of DJ-1 into the serum of patients with Parkinson's disease

(2007) Chinatsu Maita et al.   NEUROSCIENCE LETTERS